Abiopharma

🔍 Goldstein Jeffrey A (Executive)

Company: Bank of New York Mellon Corp (BK)

Report Date: 2026-04-17

Detailed Transactions and Holdings:

• Acquired 1,592 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-17 | Code: A | equity_swap_involved: false | shares_owned_after: 51,090.99 | transaction_form_type: 4 | Footnotes: F1, F3, F2, F2

Footnotes:

• F1: 1-for-1.
• F2: The deferred stock units vest on the earlier of the date of the Corporation's 2027 Annual Meeting of Shareholders or one year from the grant date. Vested deferred stock units are payable in shares of Common Stock either in a lump sum or, if the grantee has so elected, in annual installments, in each case beginning the 30th day following the grantee's termination of service as a director of the Corporation. Deferred stock units pay dividend equivalents which are reinvented in additional deferred stock units.
• F3: N/A.